(UroToday.com) Dr. Veda Giri began by providing the historical context of genetic testing in prostate cancer. Unlike germline genetic testing in breast and ovarian cancer (BRCA) and Lynch syndrome testing, prostate cancer genetic profiling began much later, around 2014. Current genomic tests for prostate cancer are summarized in the table provided below and cross-referenced with their clinical use. Multiple other genomic tests are under clinical development at the present time.